The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cancer stemness inhibition and chemosensitization: Phase 1b/II study of cancer stemness inhibitor napabucasin (BBI-608) with FOLFIRI +/- bevacizumab (Bev) administered to colorectal cancer (CRC) patients (pts).
 
Johanna C. Bendell
No Relationships to Disclose
 
Bert H. O'Neil
Consulting or Advisory Role - Amgen; Bayer; Genentech/Roche; Lilly/ImClone
Travel, Accommodations, Expenses - Merck KGaA
 
Alexander Starodub
Consulting or Advisory Role - Bayer; Sandoz
Speakers' Bureau - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Sandoz
 
Derek J. Jonker
No Relationships to Disclose
 
Thorvardur Ragnar Halfdanarson
Consulting or Advisory Role - Ipsen (Inst); Lexicon (Inst); Merrimack (Inst)
Research Funding - Boston Biomedical (Inst); Esanex (Inst); Ipsen (Inst)
 
William Jeffery Edenfield
No Relationships to Disclose
 
Bassel F. El-Rayes
No Relationships to Disclose
 
Joleen Marie Hubbard
Consulting or Advisory Role - Bayer (Inst)
Research Funding - Bayer (Inst); Boston Biomedical (Inst); Genentech (Inst); PRISM Pharma (Inst); Senhwa Biosciences (Inst)
 
Henry C. Pitot
No Relationships to Disclose
 
Timothy J. Hobday
No Relationships to Disclose
 
Youzhi Li
Employment - Boston Biomedical
Stock and Other Ownership Interests - Boston Biomedical
Travel, Accommodations, Expenses - Boston Biomedical
 
Yuan Gao
Employment - Boston Biomedical
 
Axel Grothey
Consulting or Advisory Role - Amgen (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst); Sanofi (Inst)
Research Funding - Bayer (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Eisai (Inst); Genentech/Roche (Inst); Lilly (Inst); Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Boehringer Ingelheim; Boston Biomedical; Bristol-Myers Squibb; Genentech/Roche
 
Laura Borodyansky
Employment - Boston Biomedical
Travel, Accommodations, Expenses - Boston Biomedical
 
Chiang Li
Employment - Boston Biomedical
Leadership - Boston Biomedical
Stock and Other Ownership Interests - Boston Biomedical
Consulting or Advisory Role - Boston Biomedical
Patents, Royalties, Other Intellectual Property - Boston Biomedical
Travel, Accommodations, Expenses - Boston Biomedical